Halozyme Therapeutics Inc. (HALO) Live Stock Price, Forecast & News | FX Empire

Advertisement

Advertisement

Halozyme Therapeutics Inc.
HALO
(Nasdaq - US)
N/A
38.49
-0.63 (-1.61%)
in:usd•As of: Apr 25, 2024 15:59 UTC -4
Open
38.50
High
38.75
Low
38.23

Stats

Prev. Close

39.12

Open

38.50

Day's Range

38.23 - 38.75

52 Week Range

29.85 - 45.00

YTD Change

4.14%

1 Year Change

14.66%

Market Cap

4.89B

P/E Ratio

15.34

Volume

25,637

Beta

1.25

Sector

Health Technology

Industry

Economic CalendarAll Events

Time zone: GMT

Friday, April 26th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Personal Income MoMMar	High	0.5%	0.5%	0.3%
12:30	USD	Core PCE Price Index MoMMar	High	0.3%	0.3%	0.3%
12:30	USD	PCE Price Index YoYMar	Medium	2.7%	2.6%	2.5%
12:30	USD	Personal Spending MoMMar	High	0.8%	0.6%	0.8%
14:00	USD	Michigan Consumer Sentiment FinalApr	Medium		77.8	79.4

Monday, April 29th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
14:30	USD	Dallas Fed Manufacturing IndexApr	Medium		-11	-14.4
19:00	USD	Treasury Refunding Financing Estimates	Medium

Latest News

featured

InvestorPlaceApr 25, 2024

3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition

HALO-1.61%

featured

Zacks Investment ResearchApr 24, 2024

Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term

HALO-1.61%

featured

Zacks Investment ResearchApr 18, 2024

Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why

HALO-1.61%

featured

Zacks Investment ResearchApr 18, 2024

Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know

HALO-1.61%

featured

Seeking AlphaApr 10, 2024

Halozyme's Strategic Partnerships Fueling Next-Gen Therapeutics

HALO-1.61%

featured

Zacks Investment ResearchApr 4, 2024

Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy?

HALO-1.61%

Data Vendor: Xignite Logo

Stocks

Loading

Loading

Trade With A Regulated Broker